{"id":2564,"date":"2025-03-28T15:23:32","date_gmt":"2025-03-28T07:23:32","guid":{"rendered":"https:\/\/bccmedianews.com\/?p=2564"},"modified":"2025-03-31T15:33:11","modified_gmt":"2025-03-31T07:33:11","slug":"sanctioning-illumina-acceleration-of-domestic-substitution-in-gene-sequencing","status":"publish","type":"post","link":"https:\/\/bccmedianews.com\/?p=2564","title":{"rendered":"Sanctioning Illumina: Acceleration of Domestic Substitution in Gene Sequencing"},"content":{"rendered":"\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong><br>Introduction:<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">In February 2025, China\u2019s Ministry of Commerce placed Illumina on the \u201cUnreliable Entity List\u201d and subsequently prohibited its gene sequencers from entering China, as a major countermeasure against the United States\u2019 unfair trade policies. Previously, domestic gene sequencing companies represented by MGI (\u534e\u5927\u667a\u9020) had already begun to challenge Illumina\u2019s monopoly and achieved notable results in the equipment market. With supportive policy, the process of domestic substitution for equipment will accelerate further and gradually extend to reagents and consumables.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>1. Chinese Government\u2019s Restrictions on Illumina<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>Policy Background and Specific Measures<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">On February 4, 2025, China\u2019s Ministry of Commerce included Illumina in the \u201cUnreliable Entity List,\u201d and on March 4, 2025, further prohibited the export of its gene sequencers to China. This action was based on the \u201cProvisions on the Unreliable Entity List,\u201d citing Illumina for \u201cviolating market transaction principles, interrupting normal cooperation with Chinese enterprises, and taking discriminatory measures.\u201d<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Scope of Restrictions: <\/strong>The ban mainly targets high-throughput gene sequencer exports but does not explicitly restrict reagents, consumables, or maintenance services.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Policy Intent: <\/strong>By restricting equipment imports, it aims to compel domestic substitution while retaining a buffer period for existing equipment (dependent on reagents and consumables) to avoid a technological disconnect.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Illumina\u2019s Market Position and Response Strategy<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 As the global monopolist in sequencer markets (holding 80% global share), Illumina has long dominated the Chinese market, with its revenue in Greater China reaching USD 308 million in 2024.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 In response to the ban, Illumina pre-stocked at least one year\u2019s worth of reagent inventory and hopes to maintain consumable supply to Chinese clients through localized production in Shanghai.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>2. Policy Impact on High-Throughput Sequencing Equipment Market<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>Market Restructuring: Acceleration of Domestic Substitution<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Rapid Increase in Market Share for Domestic Sequencers<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">After Illumina was listed as an unreliable entity, its market position in China was directly impacted. According to data from China Insights Consultancy, Illumina\u2019s market share fell from 82% three years ago to 35% in 2024, while domestic companies such as MGI rose to 47.3%. Analysis from Zhongcheng Medical Devices based on public bidding data showed that MGI accounted for 44.71% of procurement value in the first half of 2024. The key drivers behind this substitution include cost advantages (only one-third the cost of imports), technological breakthroughs (e.g., DNBSEQ technology, nanopore sequencing), and policy support (such as \u201cBuy Domestic\u201d policies).<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Stock Market Competition and New Market Development<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Following the restrictions on Illumina, its existing customers may turn to domestic equipment. For instance, MGI\u2019s MGISEQ-2000 has already entered the UK market, demonstrating enhanced international competitiveness of domestic devices. In addition, China\u2019s gene testing equipment market reached RMB 115 billion (approx. USD 15.9 billion) in 2024, and increasing domestic substitution will further unlock market potential.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>Adjustment of Supply Chain and Technical Ecosystem<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Short-Term Supply Chain Disruptions<\/strong><\/p>\n\n\n\n<ul style=\"font-size:20px\" class=\"wp-block-list has-open-sans-font-family\">\n<li><strong>Dependency on High-End Equipment: <\/strong>Some high-end sequencers in China still rely on Illumina\u2019s technology, and the listing may lead to short-term supply disruptions (e.g., for core reagents and chips).<\/li>\n\n\n\n<li><strong>Substitution Paths: <\/strong>According to the \u201cProvisions on the Unreliable Entity List,\u201d Chinese firms may apply for special permits to continue transactions, but the approval process may delay cooperation timelines. Additionally, Illumina\u2019s local production base in Shanghai may face operational restrictions, impacting its localization plans.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Acceleration of Long-Term Technological Autonomy<\/strong><\/p>\n\n\n\n<ul style=\"font-size:20px\" class=\"wp-block-list has-open-sans-font-family\">\n<li>Domestic Breakthroughs: MGI achieved sequencer self-reliance through the acquisition of CG, and Qitan Technology launched the nanopore sequencer QNome-3841, filling a domestic gap.<\/li>\n\n\n\n<li>Industry Chain Synergy: Domestic firms are pushing for local sourcing of raw materials (e.g., optical and fluidic components) to reduce import dependence. For example, MGI has locally substituted some high-value raw materials.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>Policy and Industry Environment as Catalysts<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 <\/strong>Policy Support for Self-Reliance<\/p>\n\n\n\n<ul style=\"font-size:20px\" class=\"wp-block-list has-open-sans-font-family\">\n<li>China uses the \u201cUnreliable Entity List\u201d to counter external blockades, while enacting the \u201cIndustrial Promotion Law\u201d to explicitly support high-tech industries such as gene sequencing.<\/li>\n\n\n\n<li>Local governments favor domestic equipment in procurement, with companies like MGI and Berry Genomics becoming dominant in bidding.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Shift in International Cooperation Models<\/strong><\/p>\n\n\n\n<ul style=\"font-size:20px\" class=\"wp-block-list has-open-sans-font-family\">\n<li>Limitations on Foreign Collaborations: Illumina\u2019s partnerships with local firms like Novogene and Berry Genomics may be impacted by the listing.<\/li>\n\n\n\n<li>Increased Requirements for Data Security and Compliance: Illumina\u2019s BaseSpace cloud platform must comply with Chinese data privacy regulations, and such cooperation may now face stricter scrutiny.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>Dual-Edged Effect of Industry Competition and Innovation<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Forcing Domestic Innovation<\/strong><\/p>\n\n\n\n<ul style=\"font-size:20px\" class=\"wp-block-list has-open-sans-font-family\">\n<li>Under pressure from the entity list, Chinese firms are increasing R&amp;D investment. For instance, MGI reduced sequencing costs to below USD 500, and Qitan Technology overcame nanopore sequencing bottlenecks.<\/li>\n\n\n\n<li>Integration of AI with sequencing is accelerating, improving data analysis efficiency and creating new application scenarios in precision medicine and agricultural breeding.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Changes in Global Competitive Landscape<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-open-sans-font-family\" style=\"font-size:20px\">Domestic substitution in China may weaken Illumina\u2019s global monopoly. In 2023, MGI accounted for 18.7% of global new installations, challenging Illumina\u2019s 80% market share.<\/li>\n\n\n\n<li class=\"has-open-sans-font-family\" style=\"font-size:20px\">Trend of \u201cde-Americanization\u201d in supply chains: China is lowering risks through local production and diversified sourcing (e.g., Europe, Southeast Asia).<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>Potential Risks and Challenges<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 Risk of Technological Gaps<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Some high-end sequencing technologies (e.g., ultra-high-throughput, single-molecule sequencing) still depend on imports. Domestic devices need further breakthroughs in accuracy and throughput.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 International Market Barriers<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Chinese companies may face tighter tech restrictions when expanding abroad. For instance, MGI faced patent lawsuits in the U.S. and Europe, requiring stronger IP strategies.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Short-Term Industry Pain<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Institutions reliant on Illumina (e.g., tertiary hospitals, research centers) may experience issues with maintenance and consumables, requiring transitions via inventory or equipment replacement.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>3. Policy Impact on Sequencing Reagents and Consumables Market<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>Short-Term: Supply Volatility and Dual-Track Response<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Dependence on Reagents and Consumables:<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Over 50% of high-throughput reagent kits in China\u2019s clinical field are based on Illumina platforms. Short-term supply may continue, but stability is questionable.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Emergency Measures:<\/strong><\/p>\n\n\n\n<ul style=\"font-size:20px\" class=\"wp-block-list has-open-sans-font-family\">\n<li>Medical institutions mitigate shortages by stockpiling.<\/li>\n\n\n\n<li>Domestic manufacturers are developing compatibility kits to attract users toward local consumables.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Long-Term: Formation of a Domestic Reagent Ecosystem<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Technology Parity and Cost Advantages:<\/strong><\/p>\n\n\n\n<ul style=\"font-size:20px\" class=\"wp-block-list has-open-sans-font-family\">\n<li>MGI\u2019s DNBSEQ-T7 paired reagents have a throughput of 6 Tb\/run and cost 40% less than Illumina\u2019s.<\/li>\n\n\n\n<li>Sansure Biotech and Berry Genomics achieved >90% localization of NIPT (non-invasive prenatal testing) reagents, with prices dropping from RMB 2,000 to RMB 800 (approx. USD 110).<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>\u2022 Industry Chain Synergy:<\/strong><\/p>\n\n\n\n<ul style=\"font-size:20px\" class=\"wp-block-list has-open-sans-font-family\">\n<li>Equipment-reagent bundling model: MGI\u2019s reagent revenue grew 38% YoY in 2023, accounting for 58% of total gene sequencing revenue.<\/li>\n\n\n\n<li>Raw material localization breakthroughs: Genemind Bio achieved domestic substitution of critical materials like DNA polymerase.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>Market Segmentation and Challenges<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 Clinical Diagnostics:<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Companion diagnostics in oncology (e.g., AmoyDx BRCA1\/2 kits) and reproductive health are seeing the fastest domestic replacement.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 Research Market:<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Due to historical data continuity, Illumina reagents remain in use, but new projects tend to prefer domestic ones. MGI offers \u201cdata comparison toolkits\u201d to verify consistency.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 High-End Reagent Barriers:<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Fields like single-cell sequencing (e.g., 10X Genomics Chromium kits) and methylation detection still rely on imports.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Risks and International Bottlenecks<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 Fragmented Supply Chain:<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">60% of domestic reagent companies have annual revenue under RMB 100 million (approx. USD 13.8 million), with weak bargaining power for raw materials and exposure to capacity fluctuation risks.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 Lack of International Certification:<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">Only 21% of domestic reagents have CE\/ISO13485 certification, limiting overseas expansion (MGI\u2019s overseas reagent revenue share &lt;15%).<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>Conclusion<\/strong><\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">China\u2019s sanction on Illumina marks a full-chain restructuring of the gene sequencing industry, from equipment to reagents:<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 Equipment: Technological advantage and policy dividends enable MGI and others to lead the market.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 Reagents: Still reliant on imports in the short term, but a closed-loop domestic ecosystem is expected by 2026, with domestic market share potentially exceeding 65%.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">\u2022 Key Battlegrounds:<\/p>\n\n\n\n<ul style=\"font-size:20px\" class=\"wp-block-list has-open-sans-font-family\">\n<li>Full localization of upstream enzyme materials (e.g., sequencing polymerase, transposase);<\/li>\n\n\n\n<li>Integrated solutions that break through international ecosystems (e.g., MGI\u2019s \u201cinstrument-reagent-data\u201d closed loop);<\/li>\n\n\n\n<li>Overcoming overseas patent and certification barriers.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\">This event not only reshapes the domestic market landscape but also accelerates China\u2019s leap from \u201cfollower\u201d to \u201cleader\u201d in the global gene sequencing value chain, laying a foundation for self-reliance in strategic sectors like precision medicine and the bioeconomy.<\/p>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"259\" data-attachment-id=\"1065\" data-permalink=\"https:\/\/bccmedianews.com\/?attachment_id=1065\" data-orig-file=\"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2024\/10\/introduce_Micheal-Wang.png?fit=1178%2C476&amp;ssl=1\" data-orig-size=\"1178,476\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"introduce_Micheal Wang\" data-image-description=\"\" data-image-caption=\"\" data-large-file=\"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2024\/10\/introduce_Micheal-Wang.png?fit=640%2C259&amp;ssl=1\" src=\"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2024\/10\/introduce_Micheal-Wang.png?resize=640%2C259&#038;ssl=1\" alt=\"\" class=\"wp-image-1065\" srcset=\"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2024\/10\/introduce_Micheal-Wang.png?resize=1024%2C414&amp;ssl=1 1024w, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2024\/10\/introduce_Micheal-Wang.png?resize=300%2C121&amp;ssl=1 300w, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2024\/10\/introduce_Micheal-Wang.png?resize=768%2C310&amp;ssl=1 768w, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2024\/10\/introduce_Micheal-Wang.png?w=1178&amp;ssl=1 1178w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<p class=\"has-open-sans-font-family wp-block-paragraph\" style=\"font-size:20px\"><strong>[Disclaimer]<\/strong>: The above content reflects analysis of publicly available information, expert insights, and BCC research. It does not constitute investment advice. BCC is not responsible for any losses resulting from reliance on the views expressed herein. Investors should exercise caution.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Introduction: In February 2025, China\u2019s Ministry of Com [&hellip;]<\/p>\n","protected":false},"author":256241814,"featured_media":2568,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_wpcom_ai_launchpad_first_post":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"{title}\n\n{excerpt}\n\n{url}","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false,"jetpack_post_was_ever_published":false},"categories":[132842,132876,132862,132846,132898,132860,132854],"tags":[],"class_list":["post-2564","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-economy","category-china-focus","category-corporate-insights","category-global-markets","category-market-reports","category-market-trends","category-data-reports"],"jetpack_publicize_connections":[],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pg46U3-Fm","jetpack-related-posts":[{"id":6211,"url":"https:\/\/bccmedianews.com\/?p=6211","url_meta":{"origin":2564,"position":0},"title":"Invasive Brain-Computer Interfaces: China Fires the First Shot","author":"revieweditor","date":"2026\u5e7406\u670823\u65e5","format":false,"excerpt":"In June 2026, Neuracle completed the world\u2019s first\u2026","rel":"","context":"\u5728\u201cBusiness\u201d\u4e2d","block_context":{"text":"Business","link":"https:\/\/bccmedianews.com\/?cat=132842"},"img":{"alt_text":"","src":"https:\/\/bccmedianews.com\/wp-content\/uploads\/2026\/03\/CEY3WQ5EYJFPTPNFZSDBI2SOO4.avif","width":350,"height":200,"srcset":"https:\/\/bccmedianews.com\/wp-content\/uploads\/2026\/03\/CEY3WQ5EYJFPTPNFZSDBI2SOO4.avif 1x, https:\/\/bccmedianews.com\/wp-content\/uploads\/2026\/03\/CEY3WQ5EYJFPTPNFZSDBI2SOO4.avif 1.5x"},"classes":[]},{"id":5663,"url":"https:\/\/bccmedianews.com\/?p=5663","url_meta":{"origin":2564,"position":1},"title":"Goldman Sachs Upgrades Cambricon, Downgrades Inspur: The Surge and Structural Upheaval of China&#8217;s Domestic AI Chips in 2026","author":"revieweditor","date":"2026\u5e7405\u670808\u65e5","format":false,"excerpt":"In the first quarter of 2026, China's domestic AI \u2026","rel":"","context":"\u5728\u201cAI &amp; Big Data\u201d\u4e2d","block_context":{"text":"AI &amp; Big Data","link":"https:\/\/bccmedianews.com\/?cat=132868"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":2215,"url":"https:\/\/bccmedianews.com\/?p=2215","url_meta":{"origin":2564,"position":2},"title":"2024 Oncology Research Review: A Revolutionary Leap in Cancer Treatment","author":"revieweditor","date":"2025\u5e7402\u670825\u65e5","format":false,"excerpt":"February 25, 2025 Introduction The year 2024 marke\u2026","rel":"","context":"\u5728\u201cBusiness\u201d\u4e2d","block_context":{"text":"Business","link":"https:\/\/bccmedianews.com\/?cat=132842"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/02\/pexels-mediocrememories-954585-e1740529348903.jpg?fit=1176%2C784&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/02\/pexels-mediocrememories-954585-e1740529348903.jpg?fit=1176%2C784&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/02\/pexels-mediocrememories-954585-e1740529348903.jpg?fit=1176%2C784&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/02\/pexels-mediocrememories-954585-e1740529348903.jpg?fit=1176%2C784&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/02\/pexels-mediocrememories-954585-e1740529348903.jpg?fit=1176%2C784&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":3911,"url":"https:\/\/bccmedianews.com\/?p=3911","url_meta":{"origin":2564,"position":3},"title":"Policy Dividends Continue to Be Released, Home-Use Medical Devices Welcome a New Growth Inflection Point","author":"revieweditor","date":"2025\u5e7409\u670802\u65e5","format":false,"excerpt":"In recent years, the home-use medical device marke\u2026","rel":"","context":"\u5728\u201cBusiness\u201d\u4e2d","block_context":{"text":"Business","link":"https:\/\/bccmedianews.com\/?cat=132842"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/09\/home-use-medical-devices-e1756795127795.png?fit=1176%2C784&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/09\/home-use-medical-devices-e1756795127795.png?fit=1176%2C784&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/09\/home-use-medical-devices-e1756795127795.png?fit=1176%2C784&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/09\/home-use-medical-devices-e1756795127795.png?fit=1176%2C784&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/09\/home-use-medical-devices-e1756795127795.png?fit=1176%2C784&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":4944,"url":"https:\/\/bccmedianews.com\/?p=4944","url_meta":{"origin":2564,"position":4},"title":"Muxi\u2019s IPO: The Industrial Restructuring Logic Behind the Breakthrough of Domestic GPUs and the Capital Frenzy","author":"revieweditor","date":"2025\u5e7412\u670819\u65e5","format":false,"excerpt":"In product planning, Muxi has built a full-stack G\u2026","rel":"","context":"\u5728\u201cAI &amp; Big Data\u201d\u4e2d","block_context":{"text":"AI &amp; Big Data","link":"https:\/\/bccmedianews.com\/?cat=132868"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/12\/66_098085a58f.png?fit=1080%2C611&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/12\/66_098085a58f.png?fit=1080%2C611&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/12\/66_098085a58f.png?fit=1080%2C611&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/12\/66_098085a58f.png?fit=1080%2C611&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/12\/66_098085a58f.png?fit=1080%2C611&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":3897,"url":"https:\/\/bccmedianews.com\/?p=3897","url_meta":{"origin":2564,"position":5},"title":"Cambricon Surpasses Kweichow Moutai to Become the Most Expensive Stock on China\u2019s A-Share Market!","author":"revieweditor","date":"2025\u5e7408\u670829\u65e5","format":false,"excerpt":"On the afternoon of August 27, a historic moment u\u2026","rel":"","context":"\u5728\u201cAI &amp; Big Data\u201d\u4e2d","block_context":{"text":"AI &amp; Big Data","link":"https:\/\/bccmedianews.com\/?cat=132868"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/08\/HA0_-CLOgPKBGIILMqCFMYCcJ8E-e1756449577520.jpg?fit=1176%2C662&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/bccmedianews.com\/wp-content\/uploads\/2025\/03\/Illumina-building-entrance.webp?fit=1200%2C675&ssl=1","_links":{"self":[{"href":"https:\/\/bccmedianews.com\/index.php?rest_route=\/wp\/v2\/posts\/2564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bccmedianews.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bccmedianews.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bccmedianews.com\/index.php?rest_route=\/wp\/v2\/users\/256241814"}],"replies":[{"embeddable":true,"href":"https:\/\/bccmedianews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2564"}],"version-history":[{"count":9,"href":"https:\/\/bccmedianews.com\/index.php?rest_route=\/wp\/v2\/posts\/2564\/revisions"}],"predecessor-version":[{"id":2575,"href":"https:\/\/bccmedianews.com\/index.php?rest_route=\/wp\/v2\/posts\/2564\/revisions\/2575"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bccmedianews.com\/index.php?rest_route=\/wp\/v2\/media\/2568"}],"wp:attachment":[{"href":"https:\/\/bccmedianews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bccmedianews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bccmedianews.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}